StockData
Elanco Animal Health Inc logo

Elanco Animal Health Inc (ELAN) stock

ELANNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 9/30129% above fair value
$25.85−0.56 (-2.12%)

Close on Nov 17, 2026Market cap $12.92BP/E –Yield –

Elanco Animal Health r&d expenses

Research and development expenses are spending on new products and technology.

Elanco Animal Health's R&D Expenses for the twelve months ending Jun 30, 2026 was $371.00M, up 4.8% year over year. For fiscal 2025 it was $368.00M, up 7.0% from the year before. The highest annual figure on record is $369.00M in fiscal 2021.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$368.00M+7.0%
FY2024Dec 31, 2024$344.00M+5.2%
FY2023Dec 31, 2023$327.00M+1.9%
FY2022Dec 31, 2022$321.00M-13.0%
FY2021Dec 31, 2021$369.00M+12.2%
FY2020Dec 31, 2020$329.00M+21.9%
FY2019Dec 31, 2019$270.00M+9.5%
FY2018Dec 31, 2018$246.60M-2.0%
FY2017Dec 31, 2017$251.70M-5.3%
FY2016Dec 31, 2016$265.80M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$92.00M0.0%
Q1 FY2026Mar 31, 2026$97.00M+3.2%
Q4 FY2025Dec 31, 2025$93.00M+14.8%
Q3 FY2025Sep 30, 2025$89.00M+2.3%
Q2 FY2025Jun 30, 2025$92.00M+3.4%
Q1 FY2025Mar 31, 2025$94.00M+8.0%
Q4 FY2024Dec 31, 2024$81.00M+2.5%
Q3 FY2024Sep 30, 2024$87.00M+1.2%
Q2 FY2024Jun 30, 2024$89.00M+9.9%
Q1 FY2024Mar 31, 2024$87.00M+7.4%
Q4 FY2023Dec 31, 2023$79.00M-1.2%
Q3 FY2023Sep 30, 2023$86.00M+10.3%
Q2 FY2023Jun 30, 2023$81.00M-1.2%
Q1 FY2023Mar 31, 2023$81.00M0.0%
Q4 FY2022Dec 31, 2022$80.00M-13.0%
Q3 FY2022Sep 30, 2022$78.00M-17.0%
Q2 FY2022Jun 30, 2022$82.00M-12.8%
Q1 FY2022Mar 31, 2022$81.00M-9.0%
Q4 FY2021Dec 31, 2021$92.00M-20.0%
Q3 FY2021Sep 30, 2021$94.00M+6.8%
Q2 FY2021Jun 30, 2021$94.00M+59.3%
Q1 FY2021Mar 31, 2021$89.00M+32.8%
Q4 FY2020Dec 31, 2020$115.00M+71.1%
Q3 FY2020Sep 30, 2020$88.00M+25.9%
Q2 FY2020Jun 30, 2020$59.00M-14.2%
Q1 FY2020Mar 31, 2020$67.00M+4.5%
Q4 FY2019Dec 31, 2019$67.20M+10.0%
Q3 FY2019Sep 30, 2019$69.90M+18.7%
Q2 FY2019Jun 30, 2019$68.80M+12.1%
Q1 FY2019Mar 31, 2019$64.10M-1.7%
Q4 FY2018Dec 31, 2018$61.10M-1.5%
Q3 FY2018Sep 30, 2018$58.90M-4.8%
Q2 FY2018Jun 30, 2018$61.40M–
Q1 FY2018Mar 31, 2018$65.20M–
Q4 FY2017Dec 31, 2017$62.00M–
Q3 FY2017Sep 30, 2017$61.90M–

More Elanco Animal Health figures

See a number that looks wrong?